RAPIDITY OF SYMPTOM CONTROL WITH UPADACITINIB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM TWO RANDOMIZED PHASE 3 STUDIES
Edward V. Loftus 1
Ken Takeuchi 2
Xiang Gao 3
Remo Panaccione 4
Dapo Ilo 5
Tricia Finney-Hayward 5
Wen Zhou 5
Silvio Danese 6
Charles Phillips
Xuan Yao
Severine Vermeire
1 Mayo Clinic,Rochester,United States
2 Tsujinaka Hospital Kashiwanoha,Kashiwa,Japan
3 The Sixth Affiliated Hospital of Sun Yat-sen University,Guangzhou,China
4 University of Calgary,Calgary,Canada
5 AbbVie Inc.,North Chicago,United States
6 Humanitas Univers
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
New to myUEG?
Social Sharing